Event to Take Place October 18-20, 2011 in Toronto, ON
TORONTO, Aug. 22, 2011 /CNW/ - Medworxx Inc. ("Medworxx") (TSXV: MWX), a leader in clinical patient flow, compliance and education solutions, announces the Medworxx Client Conference will take place October 18 - 20, 2011 at the Novotel Toronto Centre, Toronto, ON. The annual event features multiple forums on Medworxx progress, technology and corporate roadmap.
"This conference is driven by our clients' desire to interact with peers and share perspectives on optimizing their Medworxx solutions," said Dan Matlow, President and CEO, Medworxx. "The event also allows us to communicate in open forums on present and future plans for the company."
The Medworxx Client Conference draws management and clinical-level hospital staff in North America and the United Kingdom, and provides opportunities for building Medworxx insight and healthcare environmental knowledge. The conference will feature interactive sessions and presentations by Deloitte, Trillium Health Centre - ON, The Hospital for Sick Children - ON, and Southlake Regional Health Centre - ON, among others.
Medworxx clients interested in attending this year's client conference are invited to register by visiting www.medworxx.com.
In addition, Medworxx would like to report that while it is the policy of management not to comment on market rumours or speculation; Medworxx re-affirms to investors its current disclosure record. The company states that management has no material information which has not been disclosed to investors.
About Medworxx
The Medworxx Community of Care engages more than 500,000 people at over
300 hospitals across Canada, United States and United Kingdom to manage
daily challenges in clinical patient flow, and requirements in
compliance and education. Medworxx Utilization Management System - the
flagship of the Patient Flow Solution - currently serves 25% of the
patient beds in Canadian hospital. Founded in 2004, Medworxx Inc. is
based in Toronto, Ontario, Canada and serves international markets. The
company is publicly traded on the TSX Venture Exchange (TSXV: MWX). For
more information, visit www.medworxx.com.
The statements made in this press release may contain forward-looking statements that may involve a number of risks and uncertainties. Actual events or results could differ materially from the company's expectations and projections. The TSX Venture Exchange has not reviewed this press release and neither approved nor disapproved the information contained in this press release.